Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial

Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, Caleb P Skipper, Katelyn A Pastick, Margaret L Axelrod, Matthew F Pullen, Alanna A Nascene, Darlisha A Williams, Nicole W Engen, Elizabeth C Okafor, Brian I Rini, Ingrid A Mayer, Emily G McDonald, Todd C. Lee, Peter Li, Lauren J MacKenzie, Justin M Balko, Stephen J Dunlop, Katherine H Hullsiek, David R Boulware, Sarah M Lofgren on behalf of the COVID PREP team
doi: https://doi.org/10.1101/2020.09.18.20197327
Radha Rajasingham
1University of Minnesota, Minneapolis, Minnesota
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: radha@umn.edu
Ananta S Bangdiwala
1University of Minnesota, Minneapolis, Minnesota
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melanie R Nicol
1University of Minnesota, Minneapolis, Minnesota
PharmD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caleb P Skipper
1University of Minnesota, Minneapolis, Minnesota
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katelyn A Pastick
1University of Minnesota, Minneapolis, Minnesota
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret L Axelrod
2Vanderbilt University Medical Center, Nashville, Tennessee
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew F Pullen
1University of Minnesota, Minneapolis, Minnesota
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alanna A Nascene
1University of Minnesota, Minneapolis, Minnesota
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darlisha A Williams
1University of Minnesota, Minneapolis, Minnesota
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole W Engen
1University of Minnesota, Minneapolis, Minnesota
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth C Okafor
1University of Minnesota, Minneapolis, Minnesota
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian I Rini
2Vanderbilt University Medical Center, Nashville, Tennessee
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid A Mayer
2Vanderbilt University Medical Center, Nashville, Tennessee
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily G McDonald
3Research Institute of the McGill University Health Centre and the Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Todd C. Lee
3Research Institute of the McGill University Health Centre and the Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Li
4Oregon Health & Science University, Portland, OR
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren J MacKenzie
5Section of Infectious Diseases, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba
MD MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin M Balko
2Vanderbilt University Medical Center, Nashville, Tennessee
PharmD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen J Dunlop
1University of Minnesota, Minneapolis, Minnesota
6Hennepin Healthcare, Minneapolis, Minnesota
MD MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine H Hullsiek
1University of Minnesota, Minneapolis, Minnesota
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R Boulware
1University of Minnesota, Minneapolis, Minnesota
MD MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Boulw001@umn.edu
Sarah M Lofgren
1University of Minnesota, Minneapolis, Minnesota
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging virus causing the ongoing Covid-19 pandemic with no known effective prophylaxis. We investigated whether hydroxychloroquine could prevent SARS CoV-2 in healthcare workers at high-risk of exposure.

Methods We conducted a randomized, double-blind, placebo-controlled clinical trial of healthcare workers with ongoing exposure to persons with Covid-19, including those working in emergency departments, intensive care units, Covid-19 hospital wards, and first responders.

Participants across the United States and in the Canadian province of Manitoba were randomized to hydroxychloroquine 400mg once weekly or twice weekly for 12 weeks. The primary endpoint was confirmed or probable Covid-19-compatible illness. We measured hydroxychloroquine whole blood concentrations.

Results We enrolled 1483 healthcare workers, of which 79% reported performing aerosol-generating procedures. The incidence of Covid-19 (laboratory-confirmed or symptomatic compatible illness) was 0.27 events per person-year with once-weekly and 0.28 events per person-year with twice-weekly hydroxychloroquine compared with 0.38 events per person-year with placebo. For once weekly hydroxychloroquine prophylaxis, the hazard ratio was 0.72 (95%CI 0.44 to 1.16; P=0.18) and for twice weekly was 0.74 (95%CI 0.46 to 1.19; P=0.22) as compared with placebo. Median hydroxychloroquine concentrations in whole blood were 98 ng/mL (IQR, 82-120) with once-weekly and 200 ng/mL (IQR, 159-258) with twice-weekly dosing. Hydroxychloroquine concentrations did not differ between participants who developed Covid-19 (154 ng/mL) versus participants without Covid-19 (133 ng/mL; P=0.08).

Conclusions Pre-exposure prophylaxis with hydroxychloroquine once or twice weekly did not significantly reduce laboratory-confirmed Covid-19 or Covid-19-compatible illness among healthcare workers.

Key Points In this randomized clinical trial of 1483 high-risk healthcare workers, there was no significant reduction in incidence of Covid-19 with once weekly or twice weekly hydroxychloroquine compared to placebo.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04328467

Funding Statement

This work was supported by Jan and David Baszucki, Steve Kirsch, the Rainwater Charitable Foundation, the Alliance of Minnesota Chinese Organizations, the Minnesota Chinese Chamber of Commerce, and the University of Minnesota Foundation. Drs. Melanie Nicol, Radha Rajasingham, and Matthew Pullen are supported by the National Institute of Allergy and Infectious Disease (K08AI134262, K23AI138851, T32AI055433). Sarah Lofgren is supported by the National Institute of Mental Health (K23MH121220). Caleb Skipper is supported by a combined Fogarty International Center, National Institute of Neurological Disorders and Stroke grant (D43TW009345). Katelyn Pastick and Elizabeth Okafor were supported through the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at the University of Minnesota. Margaret Axelrod is supported by NIH T32GM007347 and F30CA236157. Drs. Lee and McDonald receive research salary support from the Fonds de recherche du Quebec Sante. In Manitoba research support was received from the Manitoba Medical Service Foundation and Research Manitoba. Rising Pharmaceuticals in the U.S. provided a donation of the hydroxychloroquine tablets. The REDCap software was supported by the National Institutes of Healths National Center for Advancing Translational Sciences, grant UL1TR002494. The funders had no role in trial design, trial implementation, writing of the manuscript, or the decision to submit it for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This trial was approved by the University of Minnesota Institutional Review Board, conducted under FDA Investigational New Drug (149252), and overseen by an independent DSMB. In Canada, the trial was authorized without objection by Health Canada (control number 238396), with ethics approval obtained from the University of Manitoba.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be available 1 month after publication in a peer-reviewed journal.

https://covidprep.umn.edu/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 21, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, Caleb P Skipper, Katelyn A Pastick, Margaret L Axelrod, Matthew F Pullen, Alanna A Nascene, Darlisha A Williams, Nicole W Engen, Elizabeth C Okafor, Brian I Rini, Ingrid A Mayer, Emily G McDonald, Todd C. Lee, Peter Li, Lauren J MacKenzie, Justin M Balko, Stephen J Dunlop, Katherine H Hullsiek, David R Boulware, Sarah M Lofgren
medRxiv 2020.09.18.20197327; doi: https://doi.org/10.1101/2020.09.18.20197327
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, Caleb P Skipper, Katelyn A Pastick, Margaret L Axelrod, Matthew F Pullen, Alanna A Nascene, Darlisha A Williams, Nicole W Engen, Elizabeth C Okafor, Brian I Rini, Ingrid A Mayer, Emily G McDonald, Todd C. Lee, Peter Li, Lauren J MacKenzie, Justin M Balko, Stephen J Dunlop, Katherine H Hullsiek, David R Boulware, Sarah M Lofgren
medRxiv 2020.09.18.20197327; doi: https://doi.org/10.1101/2020.09.18.20197327

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)